Skip to content
Menu

Jefferies Initiates Coverage On Haemonetics with Buy Rating, Announces Price Target of $150

Benzinga Newsdesk 1 week ago

Analyst RatingsNewsInitiationPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Jefferies analyst Young Li initiates coverage on Haemonetics (NYSE:HAE) with a Buy rating and announces Price Target of $150.

Jefferies analyst Young Li initiates coverage on Haemonetics (NYSE:HAE) with a Buy rating and announces Price Target of $150.

Read at benzinga.com

← All stock news